CRCM LP Increases Stake in Burning Rock Biotech Ltd.

CRCM LP, along with CRCM Institutional Master Fund (BVI), Ltd., CRCM LLC, and Chun R. Ding, has filed a Schedule 13G, indicating a change in their beneficial ownership of Burning Rock Biotech Ltd. ADSs. As of December 19, 2025, CRCM LP holds 486,426 ADSs, representing a 5.38% ownership stake. This acquisition was not made with the purpose of changing control of the issuer. The ADSs represent Class A Ordinary Shares of Burning Rock Biotech Ltd., with each ADS representing ten shares. The filing references the issuer's annual report on Form 20F for outstanding share information as of March 31, 2025.